- Home
- Publications
- Publication Search
- Publication Details
Title
Proliferation and significance of clinically relevant β-lactamases
Authors
Keywords
-
Journal
Annals of the New York Academy of Sciences
Volume 1277, Issue 1, Pages 84-90
Publisher
Wiley
Online
2013-01-25
DOI
10.1111/nyas.12023
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antimicrobial agents targeting bacterial cell walls and cell membranes
- (2016) K. BUSH REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES
- New β-lactam-β-lactamase inhibitor combinations in clinical development
- (2013) David M. Shlaes Annals of the New York Academy of Sciences
- Clinical Outcomes with Ertapenem as a First-Line Treatment Option of Infections Caused by Extended-Spectrum β-Lactamase Producing Gram-Negative Bacteria
- (2012) Jeffrey J Fong et al. ANNALS OF PHARMACOTHERAPY
- Metallo-β-lactamase structure and function
- (2012) Timothy Palzkill Annals of the New York Academy of Sciences
- Treatment Outcome of Bacteremia Due to KPC-Producing Klebsiella pneumoniae: Superiority of Combination Antimicrobial Regimens
- (2012) Zubair A. Qureshi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
- (2012) R. Cantón et al. CLINICAL MICROBIOLOGY AND INFECTION
- Identification and screening of carbapenemase-producing Enterobacteriaceae
- (2012) P. Nordmann et al. CLINICAL MICROBIOLOGY AND INFECTION
- Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions
- (2012) L. S. Tzouvelekis et al. CLINICAL MICROBIOLOGY REVIEWS
- A call for action
- (2012) Patrice Savard et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Fourteen years in resistance
- (2012) David M. Livermore INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration
- (2012) D. Landman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evaluation of a DNA microarray for the rapid detection of extended-spectrum -lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and NDM)
- (2012) G. Cuzon et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Current Trends in Culture-Based and Molecular Detection of Extended-Spectrum- -Lactamase-Harboring and Carbapenem-Resistant Enterobacteriaceae
- (2012) M. Gazin et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Using Nucleic Acid Microarrays To Perform Molecular Epidemiology and Detect Novel -Lactamases: a Snapshot of Extended-Spectrum -Lactamases throughout the World
- (2012) C. Lascols et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Antibiotic Resistance Is Prevalent in an Isolated Cave Microbiome
- (2012) Kirandeep Bhullar et al. PLoS One
- Spread of carbapenemase NDM-1 producers: The situation in India and what may be proposed
- (2012) Asad U. Khan et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- Rationale for the 2010 Revised Susceptibility Breakpoints for Cephalosporins, Aztreonam, and Carbapenems for Enterobacteriaceae
- (2012) M. N. Dudley Journal of the Pediatric Infectious Diseases Society
- Ecology and Evolution as Targets: the Need for Novel Eco-Evo Drugs and Strategies To Fight Antibiotic Resistance
- (2011) Fernando Baquero et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Status report on carbapenemases: challenges and prospects
- (2011) Gopi Patel et al. Expert Review of Anti-Infective Therapy
- Therapeutic options for infections withEnterobacteriaceaeproducing carbapenem-hydrolyzing enzymes
- (2011) Matthew E Falagas et al. Future Microbiology
- Genetic evolution and clinical impact in extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae
- (2011) Yong Chong et al. INFECTION GENETICS AND EVOLUTION
- Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011 on antibiotic susceptibility test reporting of Gram-negative bacilli
- (2011) M. Hombach et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Metallo-β-lactamases: a last frontier for β-lactams?
- (2011) Giuseppe Cornaglia et al. LANCET INFECTIOUS DISEASES
- Antibiotic resistance is ancient
- (2011) Vanessa M. D’Costa et al. NATURE
- The emerging NDM carbapenemases
- (2011) Patrice Nordmann et al. TRENDS IN MICROBIOLOGY
- Epidemiological Expansion, Structural Studies, and Clinical Challenges of New β-Lactamases from Gram-Negative Bacteria
- (2010) Karen Bush et al. Annual Review of Microbiology
- Three Decades of -Lactamase Inhibitors
- (2010) S. M. Drawz et al. CLINICAL MICROBIOLOGY REVIEWS
- Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae
- (2010) Karen Bush CURRENT OPINION IN MICROBIOLOGY
- Minor extended-spectrum β-lactamases
- (2010) Esragul Akinci et al. Expert Review of Anti-Infective Therapy
- Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections
- (2010) Zubair A. Qureshi et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Extended-Spectrum- -Lactamase, AmpC, and Carbapenemase Issues
- (2010) K. S. Thomson JOURNAL OF CLINICAL MICROBIOLOGY
- Updated Functional Classification of -Lactamases
- (2009) K. Bush et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- AmpC -Lactamases
- (2009) G. A. Jacoby CLINICAL MICROBIOLOGY REVIEWS
- Evidence of Increasing Antibiotic Resistance Gene Abundances in Archived Soils since 1940
- (2009) Charles W. Knapp et al. ENVIRONMENTAL SCIENCE & TECHNOLOGY
- Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system
- (2009) A. Endimiani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Mechanistic Basis for the Emergence of Catalytic Competence against Carbapenem Antibiotics by the GES Family of β-Lactamases
- (2009) Hilary Frase et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
- (2009) Patrice Nordmann et al. LANCET INFECTIOUS DISEASES
- Defining an extended-spectrum β-lactamase
- (2008) D.M. Livermore CLINICAL MICROBIOLOGY AND INFECTION
- IRT and CMT β-lactamases and inhibitor resistance
- (2008) R. Cantón et al. CLINICAL MICROBIOLOGY AND INFECTION
- Contribution of extended-spectrum AmpC (ESAC) β-lactamases to carbapenem resistance in Escherichia coli
- (2008) Hedi Mammeri et al. FEMS MICROBIOLOGY LETTERS
- Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06
- (2008) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started